HE
Franklin Genomic Advancements ETF (HELX)
BATS·Financial Services·Asset Management
$44.10
+1.78%
Mkt Cap $16.46M
Analyst Ratings
No recent rating data.
Price Target (28 analysts)
$241.50
Range $163.80 – $283.50
Implied Upside
+447.6%
Consensus $241.50 vs current $44.10